Drug profile · INN
duvelisib
COPIKTRA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
duvelisib (COPIKTRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN duvelisib
Brand COPIKTRA
Route ORAL
Formulation CAPSULE
ATC code L01EM04
Frequently asked questions
What is duvelisib?
duvelisib (COPIKTRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for duvelisib?
COPIKTRA is a marketed brand name for duvelisib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of duvelisib?
duvelisib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.